Clinical trial · Observational
Evaluation of Prognostic Scores in Patients With Upper Gastrointestinal Bleeding and Cancer
Comparison Among the Scores of Glasgow-Blacthford, Rockall and AIMS65 for the Prediction of Rebleeding and Mortality in Patients With Cancer and Upper Gastrointestinal Bleeding
NCT02508883CI-TRIAL-00024166completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective and observational study to evaluate oncologic patients that presented upper gastrointestinal bleeding with the use of some prognostic scores.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Upper Gastrointestinal Bleeding | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Upper gastrointestinal bleeding
- description
- patients with cancer who presented or were admitted in the emergency room, wards or intensive care units of the Cancer Institute of São Paulo (ICESP), with a recent episode of upper gastrointestinal bleeding.
Primary outcomes (5)
- measure
- blood transfusions administered
- timeFrame
- 30 days
- description
- The need and amount of blood transfusions administered
- measure
- Endoscopic therapy
- timeFrame
- 30 days
- description
- Hemostatic endoscopic therapy will be performed if there are findings of active or recent bleeding, under conscious or deep sedation after hemodynamic stabilization and oral fasting
- measure
- Surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed diagnosis of malignant neoplasm of any site, either located inside or outside of GI tract; * Current evidence of bleeding in the last 48 hours, either by presenting hematemesis and/or melena, with or without hemodynamic instability. Patients with hematochezia or bright red blood per rectum due to a site of bleeding in upper GI tract will also be included. Exclusion Criteria: * Age \< 18 years-old; * Suspicion or confirmation of pregnancy. * Patients with no evidence of malignant neoplasm after curative surgery or oncologic therapy.
References
Publications (0)
Data not yet available
No reference posted for this study.